Fulgent Genetics Inc (FLGT) — Capital Reinvestment Ratio
Fulgent Genetics Inc (FLGT) has a Capital Reinvestment Ratio of 0.73x as of March 2026, meaning it reinvests 1% of its operating cash flow ($7.10 Million) in capital expenditures ($5.20 Million). See FLGT equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Fulgent Genetics Inc Capital Reinvestment Ratio (2016–2024)
This chart tracks Fulgent Genetics Inc's Capital Reinvestment Ratio across 8 annual periods. Check Fulgent Genetics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Fulgent Genetics Inc (2016–2024)
Year-by-year Capital Reinvestment Ratio for Fulgent Genetics Inc from 2016 to 2024. For live market cap and broader valuation context, see market cap of Fulgent Genetics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.91x | $21.06 Million | $40.31 Million | ▲ +132.8% |
| 2023 | 0.82x | $27.00 Million | $22.21 Million | ▲ +1010.5% |
| 2022 | 0.07x | $253.52 Million | $18.77 Million | ▲ +67.3% |
| 2021 | 0.04x | $538.58 Million | $23.84 Million | ▼ -82.9% |
| 2020 | 0.26x | $140.63 Million | $36.51 Million | ▲ +21.2% |
| 2019 | 0.21x | $5.52 Million | $1.18 Million | ▼ -94.7% |
| 2017 | 4.02x | $1.33 Million | $5.36 Million | ▲ +367.9% |
| 2016 | 0.86x | $4.41 Million | $3.79 Million | — |